Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States.
Processa Pharmaceuticals stock last closed at $1.88, down 9.62% from the previous day, and has decreased 62.48% in one year. It has underperformed other stocks in the Biotechnology industry by 0.48 percentage points. Processa Pharmaceuticals stock is currently +12.57% from its 52-week low of $1.67, and -86.8% from its 52-week high of $14.24.
As of Sep 14, 2026, there are 2.79M PCSA shares outstanding. The market value of PCSA is $5.25M. In the last 24 hours, 26,800 PCSA shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy PCSA shares.
Based on our research, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you'll need to fill out some personal information so you can buy PCSA today.
Now that you have opened your account on one of the most highly reviewed stock market apps, you can securely and quickly fund your account:
Check out the walkthrough below if you need help transferring money into your new investment account.
After you have chosen the best place to buy Processa Pharmaceuticals stock, it's critical to research their stock prior to investing, so you actually understand the risk and opportunity.
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on PCSA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge PCSA's fair value.
You can access additional valuation analysis on PCSA's stock here.
You can dig deeper into what analysts are forecasting on the Processa Pharmaceuticals stock forecast page.
Over the past 12 months, executives and large shareholders at PCSA have bought more shares than they have sold.
George K. Ng, Chief Executive Officer of PCSA, was the latest PCSA insider to buy. They bought $5,900.01 worth of PCSA shares on Jul 1, 2026.
Research more about who owns PCSA stock here.
No, Processa Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main order types:
Hit the Open button and your broker will execute your order.
If you require additional help investing in stocks on eToro, watch the how to video below:
Now that you own some PCSA stock, you'll want to stay up-to-date on your new investment.
Start a watchlist to get notified of important updates regarding your PCSA stock.
To reiterate, here are the 6 steps you need to take to buy Processa Pharmaceuticals stock right now:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Processa Pharmaceuticals, add PCSA to your watchlist below.